BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32312954)

  • 1. Activation of STAT3 is a key event in TLR4 signaling-mediated melanoma progression.
    Fu XQ; Liu B; Wang YP; Li JK; Zhu PL; Li T; Tse KW; Chou JY; Yin CL; Bai JX; Liu YX; Chen YJ; Yu ZL
    Cell Death Dis; 2020 Apr; 11(4):246. PubMed ID: 32312954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. M2-polarized tumor-associated macrophages facilitated migration and epithelial-mesenchymal transition of HCC cells via the TLR4/STAT3 signaling pathway.
    Yao RR; Li JH; Zhang R; Chen RX; Wang YH
    World J Surg Oncol; 2018 Jan; 16(1):9. PubMed ID: 29338742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of STAT3 targets a subpopulation of invasive melanoma stem-like cells.
    Kulesza DW; Przanowski P; Kaminska B
    Cell Biol Int; 2019 Jun; 43(6):613-622. PubMed ID: 30958597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A TCM formula comprising Sophorae Flos and Lonicerae Japonicae Flos alters compositions of immune cells and molecules of the STAT3 pathway in melanoma microenvironment.
    Liu YX; Bai JX; Li T; Fu XQ; Guo H; Zhu PL; Chan YC; Chou JY; Yin CL; Li JK; Wang YP; Chen YJ; Yu ZL
    Pharmacol Res; 2019 Apr; 142():115-126. PubMed ID: 30797070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 4 signaling promotes the migration of human melanoma cells.
    Takazawa Y; Kiniwa Y; Ogawa E; Uchiyama A; Ashida A; Uhara H; Goto Y; Okuyama R
    Tohoku J Exp Med; 2014 Sep; 234(1):57-65. PubMed ID: 25175033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4.
    Wei CY; Wang L; Zhu MX; Deng XY; Wang DH; Zhang SM; Ying JH; Yuan X; Wang Q; Xuan TF; He AQ; Qi FZ; Gu JY
    J Exp Clin Cancer Res; 2019 Mar; 38(1):137. PubMed ID: 30922374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling.
    Tan ZB; Fan HJ; Wu YT; Xie LP; Bi YM; Xu HL; Chen HM; Li J; Liu B; Zhou YC
    J Ethnopharmacol; 2019 Mar; 232():62-72. PubMed ID: 30553869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MyD88 plays a key role in LPS-induced Stat3 activation in the hypothalamus.
    Yamawaki Y; Kimura H; Hosoi T; Ozawa K
    Am J Physiol Regul Integr Comp Physiol; 2010 Feb; 298(2):R403-10. PubMed ID: 19955495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma.
    Cao HH; Chu JH; Kwan HY; Su T; Yu H; Cheng CY; Fu XQ; Guo H; Li T; Tse AK; Chou GX; Mo HB; Yu ZL
    Sci Rep; 2016 Feb; 6():21731. PubMed ID: 26911838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties.
    Wang CH; Wang PJ; Hsieh YC; Lo S; Lee YC; Chen YC; Tsai CH; Chiu WC; Chu-Sung Hu S; Lu CW; Yang YF; Chiu CC; Ou-Yang F; Wang YM; Hou MF; Yuan SS
    Oncogene; 2018 Feb; 37(5):589-600. PubMed ID: 28991224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fraxetin suppresses the proliferation, migration, and invasion of ovarian cancer cells by inhibiting the TLR4/STAT3 signaling pathway.
    Xu R; Ruan Y; Zhang L; Gu Y; Liu M
    Immunopharmacol Immunotoxicol; 2023 Jun; 45(3):287-294. PubMed ID: 36346016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of toll-like receptor 4 in melatonin-induced cardioprotection.
    Nduhirabandi F; Lamont K; Albertyn Z; Opie LH; Lecour S
    J Pineal Res; 2016 Jan; 60(1):39-47. PubMed ID: 26465095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-21 enhances Toll-like receptor 2/4-mediated cytokine production via phosphorylation in the STAT3, Akt and p38 MAPK signalling pathways in human monocytic THP-1 cells.
    Jian L; Sun L; Li C; Yu R; Ma Z; Wang X; Zhao J; Liu X
    Scand J Immunol; 2019 Jun; 89(6):e12761. PubMed ID: 30977163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JSI-124 (Cucurbitacin I) inhibits tumor angiogenesis of human breast cancer through reduction of STAT3 phosphorylation.
    Qi J; Xia G; Huang CR; Wang JX; Zhang J
    Am J Chin Med; 2015; 43(2):337-47. PubMed ID: 25787299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non‑coding RNA DILC is involved in sepsis by modulating the signaling pathway of the interleukin‑6/signal transducer and activator of transcription 3/Toll‑like receptor 4 axis.
    Huang W; Huang L; Wen M; Fang M; Deng Y; Zeng H
    Mol Med Rep; 2018 Dec; 18(6):5775-5783. PubMed ID: 30365067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentoxifylline inhibits melanoma tumor growth and angiogenesis by targeting STAT3 signaling pathway.
    Kamran MZ; Gude RP
    Biomed Pharmacother; 2013 Jun; 67(5):399-405. PubMed ID: 23639230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginkgolide B Suppresses TLR4-Mediated Inflammatory Response by Inhibiting the Phosphorylation of JAK2/STAT3 and p38 MAPK in High Glucose-Treated HUVECs.
    Chen K; Sun W; Jiang Y; Chen B; Zhao Y; Sun J; Gong H; Qi R
    Oxid Med Cell Longev; 2017; 2017():9371602. PubMed ID: 28785380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-YA promotes invasion and angiogenesis by upregulating EZH2-STAT3 signaling in human melanoma cells.
    Xu Z; Sun Y; Guo Y; Qin G; Mu S; Fan R; Wang B; Gao W; Wu H; Wang G; Zhang Z
    Oncol Rep; 2016 Jun; 35(6):3630-8. PubMed ID: 27109360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. STAT3 Differentially Regulates TLR4-Mediated Inflammatory Responses in Early or Late Phases.
    Ahuja A; Kim E; Sung GH; Cho JY
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of BMI-1 dampens migration and EMT of colorectal cancer in inflammatory microenvironment through TLR4/MD-2/MyD88-mediated NF-κB signaling.
    Ye K; Chen QW; Sun YF; Lin JA; Xu JH
    J Cell Biochem; 2018 Feb; 119(2):1922-1930. PubMed ID: 28815730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.